A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre

The increased use of immune checkpoint inhibitors across cancer programs has created the need for standardized patient assessment, education, monitoring, and management of immune-related adverse events (irAEs). At William Osler Health System in Brampton, Ontario, a practical step-wise approach detai...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheema, Parneet K., Iafolla, Marco A. J., Nematollahi, Massey, Berco, FeRevelyn, Kaushik, Deepanjali, Matthews, Priscilla, Raskin, William R., Perdrizet, Kirstin A., Dudani, Shaan, Husain, Juhi, Balcewicz, Margaret, Kuruvilla, Philip G., Reingold, Stephen M., Conter, Henry J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870472/
https://www.ncbi.nlm.nih.gov/pubmed/35200573
http://dx.doi.org/10.3390/curroncol29020074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870472/
https://www.ncbi.nlm.nih.gov/pubmed/35200573
http://dx.doi.org/10.3390/curroncol29020074

Ejemplares similares